These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 3698914)

  • 1. Dissimilarities between the uterine estrogen receptor in cytosol of castrated and estradiol-treated rats.
    Faye JC; Fargin A; Bayard F
    Endocrinology; 1986 Jun; 118(6):2276-83. PubMed ID: 3698914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
    Attardi B; Happe HK
    Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different interaction of estradiol and antiestrogens with the estrogen receptor of rat uterus.
    Faye JC; Fargin A; Bayard F
    Mol Cell Endocrinol; 1986 Sep; 47(1-2):119-24. PubMed ID: 3743888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the antiestrogen [3H]H1285 with the two forms of the molybdate-stabilized calf uterine estrogen receptor.
    Keene JL; Ruh MF; Ruh TS
    J Steroid Biochem; 1984 Dec; 21(6):625-31. PubMed ID: 6527530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen and antiestrogen binding to rat uterine and pituitary estrogen receptor: evidence for at least two physicochemical forms of the estrogen receptor.
    Jasper TW; Ruh MF; Ruh TS
    J Steroid Biochem; 1985 Nov; 23(5A):537-45. PubMed ID: 4079371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketononestrol aziridine, an agonistic estrogen receptor affinity label: study of its bioactivity and estrogen receptor covalent labeling.
    Elliston JF; Zablocki JA; Katzenellenbogen BS; Katzenellenbogen JA
    Endocrinology; 1987 Aug; 121(2):667-76. PubMed ID: 3595536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique molecular properties of a urea- and salt-stable DNA-binding estrogen receptor dimer covalently labeled with the antiestrogen [3H]desmethylnafoxidine aziridine. A comparison with the estrogen-receptor complex.
    Hutchens TW; McNaught RW; Yip TT; Suzuki T; Li CM; Besch PK
    Mol Endocrinol; 1990 Feb; 4(2):255-67. PubMed ID: 2330004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of binding of [3H]Estradiol to the cytosol fraction of rat pancreas: comparison with sites in the cytosol of uterus.
    Boctor AM; Band P; Grossman A
    Endocrinology; 1983 Aug; 113(2):453-62. PubMed ID: 6872936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The two native estrogen receptor forms of 8S and 4S present in cytosol from human uterine tissues display opposite reactivities with the antiestrogen tamoxifen aziridine and the estrogen responsive element.
    Navarro D; León L; Chirino R; Fernández L; Pestano J; Díaz-Chico BN
    J Steroid Biochem Mol Biol; 1998 Jan; 64(1-2):49-58. PubMed ID: 9569010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of estrogen receptor turnover in uterine cells in vitro and in uteri in vivo.
    Nardulli AM; Katzenellenbogen BS
    Endocrinology; 1986 Nov; 119(5):2038-46. PubMed ID: 3533520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in uterine estrogen receptor concentrations in persistent estrous and persistent diestrous rats.
    Aihara M; Kobayashi H; Kimura T; Hayashi S; Kato J
    Endocrinol Jpn; 1988 Feb; 35(1):57-70. PubMed ID: 3396514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of two forms of molybdate-stabilized estrogen receptor.
    Ruh MF; Ruh TS
    Endocrinology; 1984 Oct; 115(4):1341-9. PubMed ID: 6479095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen.
    Monsma FJ; Katzenellenbogen BS; Miller MA; Ziegler YS; Katzenellenbogen JA
    Endocrinology; 1984 Jul; 115(1):143-53. PubMed ID: 6734512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogenic stimulation of the antiestrogen specific binding site in rat uterus and liver.
    Winneker RC; Clark JH
    Endocrinology; 1983 Jun; 112(6):1910-5. PubMed ID: 6682755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modulator which converts activated estrogen receptor to a biologically inactive aggregated form.
    Nishizawa Y; Maeda Y; Noma K; Sato B; Matsumoto K; Yamamura Y
    Endocrinology; 1981 Nov; 109(5):1463-72. PubMed ID: 6795027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of uterine estrogen receptor transformation by sodium molybdate.
    Shyamala G; Leonard L
    J Biol Chem; 1980 Jul; 255(13):6028-31. PubMed ID: 7391003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of 11 beta-chloromethylestradiol and tamoxifen aziridine as affinity labeling reagents for estrogen receptors.
    Ratajczak T; Atrache V; Antes P; Comber M; Hähnel R
    Steroids; 1988; 51(5-6):499-518. PubMed ID: 3242173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of [3H]tamoxifen in rat uterine cytosols: a comparison of swinging bucket and vertical tube rotor sucrose density gradient analysis.
    Jordan VC; Prestwich G
    Mol Cell Endocrinol; 1977 Sep; 8(3):179-88. PubMed ID: 924012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antibodies to estrogen receptor on the binding of 3H-labeled antiestrogens and androstanediol in the uterus.
    Garcia M; Greene G; Rochefort H; Jensen EV
    Endocrinology; 1982 Apr; 110(4):1355-61. PubMed ID: 7060530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased DNA binding of the estrogen receptor in an estrogen-resistant mammary cancer.
    Baskevitch PP; Vignon F; Bousquet C; Rochefort H
    Cancer Res; 1983 May; 43(5):2290-7. PubMed ID: 6403233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.